Table 1.
Experiment | % Omitted Trials | Locomotion (locomotor units/ITI) |
Shock reactivity (locomotor units/shock) |
|
---|---|---|---|---|
Free | Forced | |||
Intra-mPFC inactivation | ||||
Experiment 1.1 | ||||
Vehicle | 0.92 (0.62) | 12.50 (4.05) | 17.16 (2.63) | 2.76 (0.30) |
B/M | 6.0 (1.94)* | 8.84 (2.56) | 18.30 (2.21) | 2.77 (0.25) |
Experiment 1.2 | ||||
Vehicle | 0.83 (0.52) | 4.79 (2.49) | 18.78 (1.86) | 3.30 (0.30) |
B/M | 1.67 (0.64) | 1.88 (1.07) | 20.32 (2.41) | 2.85 (0.40) |
Intra-mPFC amphetamine | ||||
Experiment 2.1 | ||||
0 μg | 5.40 (1.61) | 6.75 (2.50) | 23.02 (2.49) | 3.14 (0.29) |
2.0 μg | 8.40 (4.48) | 10.50 (3.14) | 12.68 (2.04) | 3.20 (0.19) |
10.0 μg | 7.00 (2.67) | 6.00 (2.26) | 23.98 (2.04) | 2.93 (0.15) |
20.0 μg | 10.80 (4.70) | 15.15 (4.65) | 24.61 (1.65) | 3.03 (0.28) |
Experiment 2.2 | ||||
0 μg | 4.67 (2.47) | 8.86 (4.16) | 17.76 (1.54) | 3.24 (0.32) |
2.0 μg | 3.17 (0.87) | 7.05 (1.01) | 17.12 (1.46) | 3.19 (0.45) |
10.0 μg | 12.67 (8.22) | 12.64 (4.63) | 17.82 (1.34) | 3.06 (0.13) |
20.0 μg | 2.17 (0.67) | 6.27 (3.03) | 20.71 (1.50) | 3.50 (0.62) |
Intra-mPFC inactivation plus systemic amphetamine (1.5 mg/kg) | ||||
Experiment 3.1 | ||||
Veh, veh | 0.0 (0.0) | 5.71 (4.90) | 16.89 (1.93) | 2.68 (0.65) |
B/M, veh | 4.29 (4.29) | 2.50 (2.50) | 16.21 (2.48) | 2.51 (0.55) |
Veh, amph | 27.43 (6.64)* | 41.43 (4.94)* | 26.46 (3.14)* | 2.35 (1.05) |
B/M, amph | 16.86 (4.97)* | 30.36 (6.65)* | 24.83 (3.18) | 3.04 (0.60) |
Experiment 3.2 | ||||
Veh, veh | 0.29 (0.29) | 2.86 (2.07) | 22.97 (2.33) | 4.02 (0.28) |
B/M, veh | 2.86 (2.86) | 5.07 (2.16) | 20.94 (2.88) | 3.67 (0.25) |
Veh, amph | 22.29 (9.91) | 53.93 (3.89)* | 33.84 (2.22)* | |
B/M, amph | 18.57 (6.32) | 53.21 (3.36)* | 28.67 (2.75) |